Cargando…

Elevated HsCRP in Chronic Obstructive Pulmonary Disease: A Prospective Study of Long-Term Outcomes After Percutaneous Coronary Intervention

OBJECTIVE: Anti-inflammatory therapies are reported to have additional benefits beyond lipid control for patients with cardiovascular disease. However, no study has focused on the relationship between inflammation status and long-term outcomes for chronic obstructive pulmonary disease (COPD) patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Yitian, Qi, Yu, Seery, Samuel, Yang, Jie, Li, Chen, Wang, Wenyao, Gao, Jun, Meng, Xiangbin, Shao, Chunli, Tang, Yi-Da
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552669/ https://www.ncbi.nlm.nih.gov/pubmed/36237420 http://dx.doi.org/10.2147/COPD.S380194

Ejemplares similares

HsCRP in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Alavi, S A, et al.
Publicado: (2011)

hsCRP and ET-1 expressions in patients with no-reflow phenomenon after Percutaneous Coronary Intervention
por: Liu, Min, et al.
Publicado: (2017)

IL-6 and hsCRP in Somatic Symptom Disorders and related disorders
por: van der Feltz-Cornelis, Christina M., et al.
Publicado: (2020)

Genetic analysis of hsCRP in American Indians: The Strong Heart Family Study
por: Best, Lyle G., et al.
Publicado: (2019)

Both Low and High Postprocedural hsCRP Associate with Increased Risk of Death in Acute Coronary Syndrome Patients Treated by Percutaneous Coronary Intervention
por: Chen, Runzhen, et al.
Publicado: (2020)

GlycA, hsCRP differentially associated with MI, ischemic stroke: In the Dallas Heart Study and Multi-Ethnic Study of Atherosclerosis: GlycA, hsCRP Differentially Associated MI, Stroke
por: Riggs, Kayla A., et al.
Publicado: (2022)

Serum hsCRP in early pregnancy and preterm delivery in twin gestations: a prospective cohort study
por: Chen, Yang-yang, et al.
Publicado: (2023)

Carotid Artery Intima Media Thickness and HsCRP; Predictors for Atherosclerosis in Prediabetic Patients?
por: Parildar, Hulya, et al.
Publicado: (2013)

High sensitivity C-reactive protein (hsCRP) & cardiovascular disease: An Indian perspective
por: Kamath, Deepak Y., et al.
Publicado: (2015)

Circulating angiopoietin-like protein 8 (betatrophin) association with HsCRP and metabolic syndrome
por: Abu-Farha, Mohamed, et al.
Publicado: (2016)

Distinguishing the lipid profile of GCK-MODY patients and its correlation with hsCRP levels
por: Ping, Fan, et al.
Publicado: (2022)

Influence of hsCRP Parameter on the Occurrence of Metabolic Syndrome in Patients with Polycystic Ovary Syndrome
por: Lejman-Larysz, Katarzyna, et al.
Publicado: (2023)

The Correlation between High-Sensitivity C-Reactive Protein (hsCRP) Serum Levels and Severity of Coronary Atherosclerosis
por: Assadpour Piranfar, Mohammad
Publicado: (2014)

HDL-C to hsCRP ratio is associated with left ventricular diastolic function in absence of significant coronary atherosclerosis
por: Sun, Lufan, et al.
Publicado: (2019)

Pulmonary Arterial Pressure Response During Exercise in COPD: A Correlation with C-Reactive Protein (hsCRP)
por: Varga, Janos, et al.
Publicado: (2016)

Prognostic value of suPAR and hsCRP on acute kidney injury after cardiac surgery
por: Rasmussen, Sebastian Roed, et al.
Publicado: (2021)

Association of Netrin 1 with hsCRP in Subjects with Obesity and Recent Diagnosis of Type 2 Diabetes
por: Garcia Galindo, Jesús Jonathan, et al.
Publicado: (2022)

Prooxidant–antioxidant balance, hsTnI and hsCRP: mortality prediction in haemodialysis patients, two-year follow-up
por: Antunovic, Tanja, et al.
Publicado: (2017)

Atherogenic index of plasma for non-diabetic, coronary artery disease patients after percutaneous coronary intervention: a prospective study of the long-term outcomes in China
por: Zheng, Yitian, et al.
Publicado: (2022)

Measuring hsCRP—An Important Part of a Comprehensive Risk Profile or a Clinically Redundant Practice?
por: McCormack, James P., et al.
Publicado: (2010)

The Association of Serum hsCRP and Urinary Alpha1-Microglobulin in Patients with Type 2 Diabetes Mellitus
por: Wan, Xiaohua, et al.
Publicado: (2019)

Reduction in hsCRP levels is associated with decreased incidence of cardiovascular events in Japanese hypertensive women but not in men
por: Kim-Mitsuyama, Shokei, et al.
Publicado: (2020)

Meta-Analysis of D-Dimer, hsCRP and Cytokines in COVID-19 Severe/Critical Patients in China
por: Zhang, Jie, et al.
Publicado: (2021)

Decoding the link associated with areca nut chewing and cardiovascular disease using hsCRP as a biomarker
por: Vasanthi, V, et al.
Publicado: (2022)

OA02.01. Effect of macronutrient composition of weight loss diets on reduction of the inflammatory marker hsCRP
por: Nicklas, J, et al.
Publicado: (2012)

Association of high sensitive C-reactive protein (hsCRP) with established cardiovascular risk factors in the Indian population
por: Jeemon, Panniyammakal, et al.
Publicado: (2011)

Comprehensive analysis of circulating adipokines and hsCRP association with cardiovascular disease risk factors and metabolic syndrome in Arabs
por: Abu-Farha, Mohamed, et al.
Publicado: (2014)

Thyroid Dysfunction and Their Relation to Cardiovascular Risk Factors such as Lipid Profile, hsCRP, and Waist Hip Ratio in Korea
por: Jung, Chan Hee, et al.
Publicado: (2003)

Association of hsCRP, White Blood Cell Count and Ferritin with Renal Outcome in Chronic Kidney Disease Patients
por: Tsai, Yi-Chun, et al.
Publicado: (2012)

Predictive Role of hsCRP in Recurrent Stroke Differed According to Severity of Cerebrovascular Disease: Analysis from a Prospective Cohort Study
por: Li, Jiejie, et al.
Publicado: (2023)

Relationship Between the Reciprocal Change in Inflammation-Related Biomarkers (Fibrinogen-to-Albumin and hsCRP-to-Albumin Ratios) and the Presence and Severity of Coronary Slow Flow
por: Kayapinar, Osman, et al.
Publicado: (2019)

Clinical Value of Presepsin in Comparison to hsCRP as a Monitoring and Early Prognostic Marker for Sepsis in Critically Ill Patients
por: Hassan, Elham A., et al.
Publicado: (2019)

hsCRP Level and the Risk of Death or Recurrent Cardiovascular Events in Patients With Myocardial Infarction: a Healthcare‐Based Study
por: Carrero, Juan Jesus, et al.
Publicado: (2019)

Increased Serum Levels and Chondrocyte Expression of Nesfatin-1 in Patients with Osteoarthritis and Its Relation with BMI, hsCRP, and IL-18
por: Jiang, Lifeng, et al.
Publicado: (2013)

Effect of IL-6 and hsCRP Serum Levels on Functional Prognosis in Stroke Patients Undergoing IV-Thrombolysis: Retrospective Analysis
por: Pawluk, Hanna, et al.
Publicado: (2020)

Platelet-to-lymphocyte ratio and serum hsCRP levels in third trimester and adverse pregnancy outcomes in women with gestational diabetes mellitus
por: Tao, Jun, et al.
Publicado: (2023)

Inverse relationship between serum hsCRP concentration and hand grip strength in older adults: a nationwide population-based study
por: Kim, Beom-Jun, et al.
Publicado: (2018)

TNF-α, IL-6 and hsCRP in patients with melancholic, atypical and anxious depression: an antibody array analysis related to somatic symptoms
por: Liu, Hongmei, et al.
Publicado: (2022)

Association between ApoA1 Gene, Plasma Lipid Profile, hsCRP Level, and Risk of Arterial Stiffness in Thai Elderly
por: Supajaree, Pruttaya, et al.
Publicado: (2022)

Which Biomarker is the Best for Predicting Mortality in Incident Peritoneal Dialysis Patients: NT-ProBNP, Cardiac TnT, or hsCRP?: A Prospective Observational Study
por: Oh, Hyung Jung, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_kamufn2g263gcbpi02fg4r7v5n